Hyperinsulinemic hypoglycemia due to pathogenic INSR variants: metabolic signature, phenotypic overlap, and semidominant inheritance - Scorecard - MDSpire

Hyperinsulinemic hypoglycemia due to pathogenic INSR variants: metabolic signature, phenotypic overlap, and semidominant inheritance

  • By

  • Ramon Marcelino do Nascimento

  • Andrey dos Santos

  • Dioze Guadagnini

  • Lucas Santos de Santana

  • Augusto Cezar Junior Santomauro

  • Caroline Gouveia Buff Passone

  • Milena Gurgel Teles Bezerra

  • Larissa Garcia Gomes

  • Maria Lucia Corrêa-Giannella

  • Marcia Nery

  • Mario José Abdalla Saad

  • Delmar Muniz Junior Lourenço

  • Maria Adelaide Albergaria Pereira

  • May 7, 2026

  • 0 min

Share

Clinical Scorecard: Pathogenic Variants in the Insulin Receptor Gene Linked to Hyperinsulinemic Hypoglycemia: Metabolic Profiles, Phenotypic Similarities, and Semidominant Inheritance Patterns

At a Glance

CategoryDetail
Condition
Key MechanismsAutosomal dominant and semidominant inheritance of heterozygous pathogenic variants leading to insulin resistance and hypoglycemia
Target Population
Care Setting

Key Highlights

  • 78% of individuals with PGV-INSR present with postprandial hypoglycemia
  • All carriers exhibit insulin resistance; 60% of women have PCOS
  • Marked intrafamilial variability and phenotypic overlap among HHF5, TAIRS, and RMS
  • Distinct metabolic profile includes elevated insulin levels, normal triglycerides, and variable degrees of IR
  • Recognition of this pattern may enhance genetic counseling and clinical management

Guideline-Based Recommendations

Diagnosis

    Management

      Monitoring & Follow-up

      • Regularly assess insulin levels and metabolic profiles in affected individuals
      • Monitor for development of diabetes and other complications
      • Implement lifestyle modifications to manage insulin resistance

      Risks

        Patient & Prescribing Data

        Management strategies should focus on monitoring and addressing hypoglycemic episodes, insulin resistance, and include dietary modifications.

        Clinical Best Practices

        • Utilize a multidisciplinary approach for management involving endocrinologists and genetic counselors
        • Educate patients and families about the condition and its implications, including genetic counseling and family testing
        • Encourage lifestyle modifications to manage insulin resistance

        Related Resources & Content

        Original Source(s)

        Related Content